Author details

Full Name

Jenny Wegert

Affiliation

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37792584	TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants.	J Pathol	2024
37848532	Hallmark discoveries in the biology of Wilms tumour.	Nat Rev Urol	2024
36592003	Tumor biology, biomarkers, and liquid biopsy in pediatric renal tumors.	Pediatr Blood Cancer	2023
35445187	The genomic landscape of pediatric renal cell carcinomas.	iScience	2022
34689785	MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates.	Cancer Cell International	2021
33040424	Furosemide administration onehour before bone scintigraphy examination in horses does not improve the image quality or reduce the radiation dose rate.	Veterinary Radiology and Ultrasound	2021
31562394	High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro.	Oncogene	2020
30694527	TRIM28 haploinsufficiency predisposes to Wilms tumor.	Int J Cancer	2019
30155889	The role of TCF3 as potential master regulator in blastemal Wilms tumors.	Int J Cancer	2019
29741575	REGGAE: a novel approach for the identification of key transcriptional regulators.	Bioinformatics	2018
29915264	Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.	Nat Commun	2018
29489754	The landscape of genomic alterations across childhood cancers.	Nature	2018
29479686	Internal fixation of proximal fractures of the 2nd and 4th metacarpal and metatarsal bones using bioabsorbable screws.	Australian Veterinary Journal	2018
29085664	TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia.	J Pathol Clin Res	2017
27432915	Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.	J Clin Oncol	2016
25670083	Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.	Cancer Cell	2015
25749049	Multiple mechanisms of MYCN dysregulation in Wilms tumour.	Oncotarget	2015
22034155	Characterization of primary Wilms tumor cultures as an in vitro model.	Genes Chromosomes Cancer	2012
21913182	Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.	Int J Cancer	2012
22067876	Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro.	Mol Cancer	2011
20332316	Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.	Clin Cancer Res	2010
19760609	WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.	Genes Chromosomes Cancer	2009
19789318	Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.	Clin Cancer Res	2009
18260125	New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors.	Genes Chromosomes Cancer	2008
17897883	Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.	International Journal of Medical Microbiology	2008
15635669	Synthesis of linear and cyclic phosphopeptides as ligands for the N-terminal SH2-domain of protein tyrosine phosphatase SHP-1.	Journal of Peptide Science	2005